Med-Cann 2020 Speakers

Golan Bitton is the CEO and CO-Founder of UNIVO since 2016, one of the first Cannabis companies that entered the stock market in Israel. Golan has 22 years of managerial experience in the Israeli Ministry of Defense. He Implemented and managed multi-million-dollar projects for the Israeli Government. Golan holds a B.A. in Economics from Max Stern Academic College and Computer Engineering from Negev University.

Dr. Grinberg is a top expert in the field of Cannabis research and development which hold several patents in the field of cannabis and cancer. She is a certified CRA and was involved in the cannabis based- clinical trials in Israel. Today Dr. Grinberg serves as Medikana cannabis based online data platform CEO`s.

Dr. Amy Tanti is currently heading the Quality Assurance and Drug safety (pharmacovigilance) team at Mater Malta Operating Ltd. Materia is a cannabis company, with manufacturing capabilities in Malta, a global head office in Canada, and distribution hubs in UK, Germany and Denmark. Prior to this role, she held a number of scientific roles at the Malta Medicines Authority, European Medicines Agency and private industry where she was responsible for assessing studies within drug dossiers. She is also co-founder at All Life Sciences – a niche firm specializing in recruitment for the life sciences industry.

Dr Andrew Agius is the founder and medical director of The Pain Clinic, an integrative medical centre for the interdisciplinary management of patients with chronic pain. Dr Agius has been advocating for a better understanding the medicinal properties of cannabis and was the first doctor in Malta to recommend CBD and medical cannabis to his patients as an alternative to pharmaceutical medication.

Thomas Grima is a Medical scientist and currently the Medical Scientific Liason (MSL) for Medical Cannabis at Pharma.Mt Ltd. He possesses a BSc (Hons) in Biomedical Sciences from the University of Bedfordshire and an MSc in Biomaterial and Tissue Engineering from the University College London. Having a background working in cutting edge medicine such as the GMP production of stem cells, gene therapy and oncolytic immunotherapy, while more recently working on educating the Maltese Medical scene about medical cannabis and its plethora of uses as a medical treatment.

Cannabis Patient Advocacy & Support Services (CPASS) Chair & Co-founder to Nurses Arm. A former MP under Secretary of State for NHS. Chair of Prime Minister Commissions Future of Nursing & Midwifery. RN Registered Nurse NDN National District Nurse. FQNI Fellow Queens Nursing Institute. FRCN Fellow Royal College of Nurses. FAAN Fellow American Academy of Nursing.

JP Fabri is a Co-Founding Partner of Seed Consultancy, a purpose-driven boutique business advisory firm. An economist by profession, JP has amassed local and international experience both in the private and public sector. JP formed part of the private office of the former Prime Minister of Malta and Governor of the Central Bank of Malta. He also has international policy advisory experience after having advised nine governments on economic development. JP is a visiting lecturer at the University of Malta.

Stephen’s career began in the investment banking division of one of Canada’s premier banks as a portfolio manager specializing in derivatives. He eventually took his experience co-founding the private equity firm Huxton Black LTD. Huxton Black operates as a hybrid robo-advisor portfolio management firm which raises capital and consults in the cannabis space.

After a sports accident rendering him in a wheelchair for 6 months, Stephen learned of the medical benefits of cannabis after quitting a severe opioid addiction cold turkey after 2 months of consuming 6mg of Dilaudid he was prescribed to take every 4 hours. This prescription was meant to last months and then continue indefinitely with a smaller dosing. Stephen used his finance background and newfound passion for the medical merits of cannabis to serve as the CEO of one of Huxton Black’s cannabis ventures called Hello Cannabis Corp. The company is now involved in 8 different projects across 3 continents after branching out from its original focus of educating physicians, unions, employers, and private corporations on the solutions surrounding medical cannabis programs. Hello Cannabis has now rapidly grown to become one of Canada’s most exciting vertically integrated cannabis companies after opening one of the first legal dispensaries in Canada with over 10 others in the queue for 2021 opening dates.

Prior to founding Hello Cannabis, Stephen founded and served as President of Cannoleum Inc (Now operating as GR Genetics) which was acquired by the Canadian licensed producer Green Relief. GR Genetics focus is exclusively on the genetic cultivation and propagation of medical cannabis plants.

With over 20 years of experience across relevant and regulated consumer sectors, a deep understanding of commercial, trade, and marketing needs, along with a strong grasp of cannabis, as an active consumer packaged-good ingredient, Jenn is a valuable partner for companies looking to catalyze their market positions, and build strong, smart sustainable cannabis businesses.

As President of CBD Strategy Group and Founder/CEO of the Cannabis Education Guild, Jenn helps domestic and global businesses thrive inside the box of cannabis regulation, and offers education in the commercial and medical cannabis space. She also leverages this leadership and expertise by serving as a member of the board for the National Institute of Cannabis Investors, and a mentor for Grow Tech Labs.

Over the last four years, Jenn has spoken at over 40 Cannabis conferences in Canada, the U.K., Jamaica, the U.S., and Asia. She has also been interviewed and cited across multiple national and international publications, and continues to work with the media to help drive practical and valuable sector information. Recently Jenn was recognized in the Top 100 Canadians Professionals 2020 edition.